DexCom (DXCM) Shares Get Boost From Wunderlich Initiation
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $68.10 -3.66%
Rating Summary:
30 Buy, 8 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Rating Summary:
30 Buy, 8 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Join SI Premium – FREE
Shares of DexCom (Nasdaq: DXCM) are trading at intraday highs, currently up $0.43 (+5.04%) to $8.97. However, the stock has been beaten down over the past year...52-wk range is $6.75 - 16.91.
There are no significant news releases, but this morning, Wunderlich Securities initiated coverage on the stock with a Buy rating and $12 price target.
The firm said DexCom would make a great acquisition target for one of the larger diabetes players.
DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers in the hospital for the treatment of both diabetic and non-diabetic patients.
There are no significant news releases, but this morning, Wunderlich Securities initiated coverage on the stock with a Buy rating and $12 price target.
The firm said DexCom would make a great acquisition target for one of the larger diabetes players.
DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers in the hospital for the treatment of both diabetic and non-diabetic patients.
Create E-mail Alert Related Categories
New Coverage, RumorsRelated Entities
Wunderlich SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
